2/21
02:23 pm
prph
ProPhase Labs, Inc. (NASDAQ: PRPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
Low
Report
ProPhase Labs, Inc. (NASDAQ: PRPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.